Moreover, NKILA silencing in metastatic tumor infiltrating lymphocytes and CAR T cells can overcome tumor immune escape and improve the efficacy of adoptive T cell therapy in cancer treatment (32). The gene discussed is NKILA; the disease is neoplasm.